NYSE · MD
Healthcare · Medical - Care Facilities
$29.82
Up+$0.64 (+2.19%)
Updated Nov 1, 2026, 7:23 PM
SID Score
7.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · MD
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
MD closed at $29.82 after 20 trading sessions, up 14.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $29.48 | $29.97 | $29.0702 | $29.82 | 1.11M |
| Oct 29, 2026 | $30.55 | $30.55 | $28.90 | $29.18 | 832.56K |
| Oct 28, 2026 | $29.78 | $29.78 | $28.59 | $28.91 | 656.64K |
| Oct 27, 2026 | $29.04 | $29.1299 | $28.52 | $28.84 | 668.61K |
| Oct 26, 2026 | $29.36 | $30.045 | $28.89 | $29.04 | 670.92K |
| Oct 23, 2026 | $29.41 | $29.70 | $28.985 | $29.29 | 574.87K |
| Oct 22, 2026 | $28.23 | $29.685 | $28.00 | $29.55 | 1.09M |
| Oct 21, 2026 | $27.86 | $28.23 | $27.54 | $28.10 | 458.24K |
| Oct 20, 2026 | $27.60 | $28.29 | $27.30 | $28.08 | 707.86K |
| Oct 19, 2026 | $27.18 | $27.625 | $27.18 | $27.30 | 454.77K |
| Oct 16, 2026 | $27.90 | $28.02 | $27.13 | $27.38 | 535K |
| Oct 15, 2026 | $27.285 | $27.78 | $27.285 | $27.76 | 479.09K |
| Oct 14, 2026 | $26.46 | $27.20 | $26.46 | $27.06 | 1.16M |
| Oct 13, 2026 | $27.00 | $27.08 | $26.475 | $26.61 | 461.06K |
| Oct 12, 2026 | $26.64 | $27.04 | $26.56 | $26.92 | 487.33K |
| Oct 9, 2026 | $26.35 | $26.86 | $26.33 | $26.64 | 518.04K |
| Oct 8, 2026 | $25.70 | $26.35 | $25.54 | $26.24 | 729.99K |
| Oct 7, 2026 | $25.81 | $26.40 | $25.72 | $25.83 | 655.82K |
| Oct 6, 2026 | $26.27 | $26.51 | $25.70 | $26.00 | 667.75K |
| Oct 5, 2026 | $25.90 | $26.46 | $25.5901 | $26.10 | 953.19K |
The latest Smart Investors Daily articles mentioning MD.
Company
Market Activity
Research & News
MD research
Company profile and research snapshot.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Truist Securities | Hold | — |
| Aug 19, 2026 | Jefferies | Hold | — |
| Aug 6, 2026 | UBS | Neutral | — |
| Jul 14, 2026 | Truist Securities | Hold | — |
| May 12, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
ChartMill · Oct 24, 2026
Pediatrix (MD) screens as a decent value stock: cheap valuation, solid profitability and manageable debt, though its growth outlook is modest.
Yahoo · Oct 23, 2026
Pediatrix Medical Group has delivered a strong share price run in recent years, and the question now is whether that move lines up with the cash the business can realistically generate. With the stock changing hands around US$29.55, investors are asking if the current valuation is fully supported by its underlying cash flows. Over the past 3 years Pediatrix Medical Group has returned 154.1%, which puts a lot of weight on whether its cash generation can support that kind of share price...
Yahoo · Oct 20, 2026
FORT LAUDERDALE, Fla., October 20, 2026--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
Yahoo · Oct 14, 2026
Pediatrix Medical Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.6%. The stock now trades at $26.61, marking a 17.7% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MD.
